RCMI Coordinating Center (RCMI CC) Header Logo

Connection

William A. Boisvert to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications William A. Boisvert has written about Drug Evaluation, Preclinical.
William A. Boisvert
Connection Strength
0.078
Drug Evaluation, Preclinical
  1. Gonz?lez-Bl?zquez R, Alcal? M, Fern?ndez-Alfonso MS, Steckelings UM, Lorenzo MP, Viana M, Boisvert WA, Unger T, Gil-Ortega M, Somoza B. C21 preserves endothelial function in the thoracic aorta from DIO mice: role for AT2, Mas and B2 receptors. Clin Sci (Lond). 2021 05 14; 135(9):1145-1163.
    View in: PubMed
    Score: 0.043
  2. D'Antoni ML, Mitchell BI, McCurdy S, Byron MM, Ogata-Arakaki D, Chow D, Mehta NN, Boisvert WA, Lefebvre E, Shikuma CM, Ndhlovu LC, Baumer Y. Cenicriviroc inhibits trans-endothelial passage of monocytes and is associated with impaired E-selectin expression. J Leukoc Biol. 2018 12; 104(6):1241-1252.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support